ArticleNeoplasia (New York, N.Y.)2026

Rational payload selection enables high antitumoral efficacy of an anti-EGFR antibody-drug conjugate against ovarian tumors.

Sheila Almaraz-Postigo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.